Inhibition of Cancer Cell Proliferation

Inhibition of cancer cell proliferation is a therapeutic strategy aimed at stopping or slowing the division and growth of malignant cells. This involves targeting key molecular pathways and processes that drive uncontrolled cell division, including cell cycle regulation, signal transduction, epigenetic modifications, and receptor-mediated mechanisms. Approaches can range from small molecule inhibitors to natural compounds and combination therapies, chosen based on the specific molecular profile and characteristics of the cancer.

Other names

Suppression of cancer cell growthAnti-proliferative therapyCell cycle inhibition

Inhibition of cancer cell proliferation involves targeting various molecules and pathways crucial for cell division, growth, and survival. This includes blocking cell cycle regulators (CDKs, Wee-1), interfering with signaling pathways (RAF/MEK/ERK, PI3K/Akt/mTOR), modifying epigenetic processes (HDAC inhibition), and exploiting receptor-mediated mechanisms. Some approaches also promote apoptosis in conjunction with proliferation inhibition.